NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Regenesis Biomedical, Inc.

Regenesis Biomedical, Inc.

Private
Scottsdale, ArizonaHealthcare & Life Scienceshttps://regenesisbio.com/

Last Round

Series C

Jun 6, 2011

Est. Valuation

$30M

Total Funding Raised

$8.63M

Company Overview

Regenesis Biomedical, Inc. is a medical device company that researches, designs, manufactures, and sells energy-based medical products for non-invasive pain management.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

pulsed electromagnetic fieldPEMFnon-drug pain reliefpain management deviceshortwave diathermyhome use medical devicenon-invasive pain managementenergy-based medicinedurable medical equipmentDMEpostoperative paindiabetic neuropathychronic pain managementVA medical supplierFDA cleared device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Regenesis Biomedical, Inc. Comparables

Compare Regenesis Biomedical, Inc. with similar companies based on industry and business-model similarity.

Regenesis Biomedical, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Caerus Corp
83%
Electrome
76%
Zynex Inc
71%

Regenesis Biomedical, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 6, 2011
Series BSep 5, 2006
Series AApr 26, 2002

Regenesis Biomedical, Inc. Investors

Notable investors and investment history

Regenesis Biomedical, Inc. investors
InvestorRounds
Solstice CapitalSeries C, Series A
Tucson VenturesSeries A
TGap VenturesSeries C
Village VenturesSeries A
Fulcrum Equity PartnersSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 6, 2011

    $5.3M round led by TGap Ventures and Fulcrum Equity Partners.

  • Sep 5, 2006

    $528K round completed.

Regenesis Biomedical, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Regenesis Biomedical, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Regenesis Biomedical, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersScottsdale, Arizona
Year Founded1996
Last FundingJun 6, 2011

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.